Volume 34, Issue 6 (9-2026)
JSSU 2026, 34(6): 10286-10289 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ghadiri-Anari A. Obesity: Necessity of Re-Evaluating Therapeutic Approaches and Health Policies. JSSU 2026; 34 (6) :10286-10289
URL: http://jssu.ssu.ac.ir/article-1-6737-en.html
URL: http://jssu.ssu.ac.ir/article-1-6737-en.html
Abstract: (28 Views)
Introduction: Obesity represent a complex, chronic, and relapsing medical disorder. The associated global mortality and socioeconomic burden remain considerable worldwide. Innovative pharmacological interventions, such as GLP-1 receptor agonists (e.g., Tirzepatide), have fundamentally changed clinical weight management. Meanwhile, Metabolic surgery remains the most durable option for high risk patients. Consequently, healthcare systems must accept obesity as a achronic disease entity and provide insurance coverage for both medical and surgical treatments to promote equity across public healthcare.
Keywords: Obesity management, Metabolic surgery, Chronic disease, Public health policy, GLP-1 receptor agonists
Type of Study: Editor- in- Chief Lecture |
Subject:
other
Received: 2026/07/19 | Accepted: 2026/09/6 | Published: 2026/09/6
Received: 2026/07/19 | Accepted: 2026/09/6 | Published: 2026/09/6
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
